Wondercel Biotech (shenzhen)

This early-phase study is testing a new type of cell therapy called UWD-00B for people with multiple myeloma that has come back or stopped responding to standard treatments. The therapy uses genetically modified immune cells designed to target and attack the cancer. About 30 part…

This early-stage study is testing a new type of cancer treatment called universal CAR-T cells (REVO-UWD-03) for people with advanced liver cancer or lung cancer. The treatment uses immune cells from healthy donors, engineered to attack cancer, rather than using the patient's own …

This early-stage study is testing a new type of CAR-T cell therapy for people with metastatic colorectal cancer that has not responded to standard treatments. Instead of using the patient's own cells, this 'universal' therapy uses modified immune cells from healthy donors. The ma…

This early-phase study is testing a new type of cell therapy called universal CAR-T (UWD-CD19) for people with B-cell cancers like lymphoma or leukemia that have come back or not responded to standard treatments. The goal is to see if this 'off-the-shelf' therapy, made from donor…